Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Gliosarcoma × Introns × Clear all

Sponsor

Conditions

Melanoma 12 Multiple Myeloma 3 Neoplasms 2 Colorectal Neoplasms 2 Carcinoma, Renal Cell 2 Breast Neoplasms 2 Uveal Melanoma 1 Triple Negative Breast Neoplasms 1 Small Cell Lung Carcinoma 1 Recurrence 1 Peritoneal Neoplasms 1 Pancreatic Neoplasms 1 Neuroendocrine Tumors 1 Neoplasms, Plasma Cell 1 Neoplasm Metastasis 1 Lymphoma, Follicular 1 Lymphoma 1 Lung Neoplasms 1 Leukemia-Lymphoma, Adult T-Cell 1 Leukemia 1 Hematologic Neoplasms 1 Breast Carcinoma In Situ 1

Interventions

Temozolomide 48 Bevacizumab 31 Radiotherapy 24 Radiation 11 Erlotinib Hydrochloride 11 Radiotherapy, Intensity-Modulated 7 Radiotherapy, Conformal 7 Irinotecan 6 Vorinostat 5 Immunoglobulin G 4 Disulfides 4 Carmustine 4 plerixafor 3 carmustine, poliferprosan 20 drug combination 3 Sorafenib 3 Sirolimus 3 Radiosurgery 3 Magnetic Resonance Spectroscopy 3 Everolimus 3 Dasatinib 3 Bortezomib 3 veliparib 2 vandetanib 2 temsirolimus 2 tandutinib 2 sargramostim 2 pazopanib 2 ferric pyrophosphate 2 cediranib 2 Topotecan 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡